Efficiency of Lentiviral Vectors Pseudotyped with LCMV-G in Gene Transfer to Ldlr−/−ApoB100/100 Mice
Genes · 2026
DOI: 10.3390/genes17010060 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes, 2026. Verfasst von Alisa Nousiainen und 6 weiteren Autor:innen. Beteiligte Einrichtung: A. I. Virtanen Institutefor Molecular Sciences, University of Eastern Finland, 70211 Kuopio, Finland. Hauptthemen laut MEDLINE: Genetic Vectors, Receptors, LDL, Lentivirus, Lymphocytic choriomeningitis virus. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Research Council of Finland, AFM Telethon foundation, Finnish Cultural Foundation.
Abstract (Originalsprache)
Background/Objectives: Lentiviral vectors (LVs) are most commonly pseudotyped with the vesicular stomatitis virus glycoprotein (VSV-G), which lends LVs a wide tropism as it uses the low-density lipoprotein receptor (LDLR) as the main receptor for cell entry. In some gene therapy and research applications, however, alternative pseudotypes can be useful. In this work, we characterized LVs pseudotyped with lymphocytic choriomeningitis virus (LCMV) glycoprotein, particularly in gene transfer to an LDLR-deficient mouse strain used to model cardiovascular disease, Ldlr−/−ApoB100/100.
Methods
LCMV-LVs were used in vitro to test their transduction efficiency across a variety of cell types. In vivo, the gene transfer efficiency, LV-specific immune responses and biodistribution of VSV-G-LVs and LCMV-LVs were compared after systemic gene transfer.
Results
In vitro, LCMV-LVs transduced all tested cell types at high efficiency without the use of transduction enhancers. In vivo, VSV-G-LVs showed a higher gene transfer efficiency at the same LV dose, but increasing the LCMV-LV dose enhanced the measured vector copy numbers. With both pseudotypes, most of the vector accrued in the liver, but with LCMV-LVs, a larger portion of the measured vector copies were found in the lungs. VSV-G-LVs also generated a higher titer of LV-specific IgG antibodies. The gene transfer efficiency of LCMV-LVs was affected by the mouse diet, with a high-fat diet decreasing the transduction.
Conclusions
LCMV-LVs can be used as a substitute for VSV-G-LVs if an alternative pseudotype is required; however, they may require the use of a higher LV dose.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- A. I. Virtanen Institutefor Molecular Sciences, University of Eastern Finland, 70211 Kuopio, Finland.
- Heart Center and Gene Therapy Unit, Kuopio University Hospital, 70210 Kuopio, Finland.
ORCID-Profile: Alisa Nousiainen, Anna-Kaisa Ruotsalainen, Diana Schenkwein, Seppo Ylä-Herttuala
Förderung
- Research Council of Finland
- AFM Telethon foundation
- Finnish Cultural Foundation
- Maud Kuistila Memorial Foundation
- Research Council of Finland, GeneCellNano Flagship
Zitieren
APA
Nousiainen, A., Ruotsalainen, A. K., Hokkanen, K., Laidinen, S., Tawfek, A., Schenkwein, D., & Ylä-Herttuala, S. (2026). Efficiency of Lentiviral Vectors Pseudotyped with LCMV-G in Gene Transfer to Ldlr−/−ApoB100/100 Mice. Genes. https://doi.org/10.3390/genes17010060
Vancouver
Nousiainen A, Ruotsalainen AK, Hokkanen K, Laidinen S, Tawfek A, Schenkwein D, et al. Efficiency of Lentiviral Vectors Pseudotyped with LCMV-G in Gene Transfer to Ldlr−/−ApoB100/100 Mice. Genes. 2026. doi:10.3390/genes17010060
BibTeX
@article{Nousiainen2026,
author = {Nousiainen, Alisa and Ruotsalainen, Anna-Kaisa and Hokkanen, Krista and Laidinen, Svetlana and Tawfek, Ahmed and Schenkwein, Diana and Ylä-Herttuala, Seppo},
title = {Efficiency of Lentiviral Vectors Pseudotyped with LCMV-G in Gene Transfer to Ldlr−/−ApoB100/100 Mice},
journal = {Genes},
year = {2026},
doi = {10.3390/genes17010060}
}
EUVIMED